Smoking Cessation Drugs Market Size & CAGR (2023-2031)
The Smoking Cessation Drugs Market is expected to register a CAGR of 10.5% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Product (Drug therapy, E-cigarettes, Nicotine replacement therapies, and Nicotine Sublingual tablets). The report is segmented by Distribution (Drug stores, Hospital pharmacies, Online pharmacies, and Retail pharmacies). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Smoking Cessation Drugs Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Smoking Cessation Drugs Market Segmentation
Product- Drug therapy
- E-cigarettes
- Nicotine replacement therapies
- Nicotine Sublingual tablets
- Drug stores
- Hospital pharmacies
- Online pharmacies
- Retail pharmacies
Strategic Insights
Smoking Cessation Drugs Market Growth Drivers- Awareness of Health Risks is Increasing: It is primarily responsible for the emergence and growth prospects of the sector for the market smoking cessation drugs. Government agencies, health professionals, and advocacy groups have intensified the public awareness campaigns on the side effects of smoking, which include lung cancer, heart disease, and respiratory problems, as well as the most prominent smoking cessation products, as motivated smokers enlist products for quitting in safe and effective ways. Other measures such as public health campaigns and warnings on the packages have been and continue to capitalize more on the impact of anti-smoking laws.
- Government Regulations and Anti-Smoking Policies: All government have stringent regulations on smoking, coupled by higher taxes on the product, public smoking bans, and regulations with promotion of smoking cessation programs. The regulations are meant to discourage smoking; in addition, they push towards quitting doing so by helping a smoker avoid very easily temptation. Their emerging innovations include a variety of smoking cessation drugs, nicotine replacement therapies (NRTs), such prescription medications, and newer approaches that easily target the population.
- Recent Developments in Pharmaceutical Innovations: Continuous research and development have given birth to more effective and tailored treatment methods for patients who need using smoking cessation drugs. Some of these include varenicline (Chantix), bupropion (Zyban), as well as nicotine replacement therapies, which have been proven to reduce smoking and withdrawal effects. The current research effort is into the finalization of new drug delivery systems, such as e-cigarettes, transdermal patches, and oral tablets that provide smokers with options that are less obtrusive.
- Emphasis on Custom-Made Medicine: Personalized medicine now has an edge over most drugs in developed markets for smoking cessation. Apart from increased usage of genomics and pharmacogenomics, custom-made treatments address the lifestyle and smoking history of the patients, making them personalized for better chances at successful quitting. In addition to smoking, personalized medicine will be able to cater to common problems that accompany dependency, like anxiety and depression that reduce the efficacy of regular cessation methods.
- Emergence of Digital Programs for Smoking Cessation: Integrating smoking cessation schemes with digital technology is one of the most important trends in recent years. Mobile apps, virtual counseling, online support groups, and wearable devices that keep smoking habits and health parameters in check have brought about amazing changes in a smoker's access to the cessation wellness program. In addition, prices for digital solutions can be a lot more economical when compared to face-to-face therapy. They often allow continuous monitoring of intervention, which may be beneficial for a smoker to stay on the right track and receive timely intervention that could enhance the overall effectiveness of using these medications.
- Growing Non-Nicotine Medicines Adoption: NRTs have been the tried-and-true first-line treatment method for smoking cessation for many years. However, the trend has been moving away from increasing numbers of smokers ever willing to try non-nicotine drugs. Emerging into their popularity are varenicline and bupropion, both of which have actions in the central nervous system neurotransmitter systems in reducing craving and withdrawal symptoms. These medications are favored by some smokers because they do not contain nicotine, which perpetuates dependence.
- Men and Adolescents as Focus Points: Programs to quit smoking, specifically targeting women and adolescents, become an increasing space for opportunity. Because of the various barriers that women face such as weight gain and hormonal changes due to cessation, targeted treatment can be effective. Similarly, adolescents generally experience problems such as peer pressure and social acceptance that usually hinder them from quitting. It is about designing drugs for quitting that would be either convenient for these populations or about developing specifically targeted promotional campaigns that will address such particular needs.
- Develop Combination Therapies: It is also possible to develop combined therapy targeting various dimensions of smoking dependence, such as simultaneous treatment of both physical dependence and behavioral dependence through the use of their combination. That would help with long-term continuation of therapy. The combination of nicotine replacement and antidepressants or anti-anxiety drugs is another examples of combination therapies eliminating from the perspectives of dealing with the comprehensive nature of the phenomenon of dependence on smoking for their cessation.
- Cooperation from Companies on Digital Health: For tobacco cessation, digitalized health tools increasingly develop into a cure aspiration, and therefore pharmacy is standing up a unique opportunity to work with their counterparts in the digital health arena. These digital platforms will empower smoking cessation drug therapy inclusion in mobile applications and wearable devices to allow a more varied treatment option that incorporates behavior and medication into the therapy such that it maximizes engagement, optimizes adherence to treatment completion, and augments efficacy in quitting smoking.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Smoking Cessation Drugs Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Smoking Cessation Drugs Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Players operating in the market are British American Tobacco PLC, Dr. Reddy's Laboratories, Fontem Ventures, GlaxoSmithKline, Imperial Tobacco, Johnson & Johnson, Kimree Technology, Nicotek LLC
Nicotine replacement therapies segment, by product, dominated the market in 2023.
North America region dominated the Smoking Cessation Drugs market in 2023.
Men and Adolescents as Focus Points act as a opportunity for growth of the market in forecast period.
The Smoking Cessation Drugs Market is estimated to witness a CAGR of 10.5% from 2023 to 2031
The major factors driving the Smoking Cessation Drugs market are:
1. Awareness of Health Risks is Increasing
2. Government Regulations and Anti-Smoking Policies
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Smoking Cessation Drugs Market - By Product
1.3.2 Smoking Cessation Drugs Market - By Distribution
1.3.3 Smoking Cessation Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SMOKING CESSATION DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SMOKING CESSATION DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SMOKING CESSATION DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. SMOKING CESSATION DRUGS - GLOBAL MARKET OVERVIEW
6.2. SMOKING CESSATION DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. SMOKING CESSATION DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. DRUG THERAPY
7.3.1. Overview
7.3.2. Drug therapy Market Forecast and Analysis
7.4. E-CIGARETTES
7.4.1. Overview
7.4.2. E-cigarettes Market Forecast and Analysis
7.5. NICOTINE REPLACEMENT THERAPIES
7.5.1. Overview
7.5.2. Nicotine replacement therapies Market Forecast and Analysis
7.6. AND NICOTINE SUBLINGUAL TABLETS.
7.6.1. Overview
7.6.2. and Nicotine Sublingual tablets. Market Forecast and Analysis
8. SMOKING CESSATION DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION
8.1. OVERVIEW
8.2. DISTRIBUTION MARKET FORECASTS AND ANALYSIS
8.3. DRUG STORES
8.3.1. Overview
8.3.2. Drug stores Market Forecast and Analysis
8.4. HOSPITAL PHARMACIES
8.4.1. Overview
8.4.2. Hospital pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACIES
8.5.1. Overview
8.5.2. Online pharmacies Market Forecast and Analysis
8.6. AND RETAIL PHARMACIES.
8.6.1. Overview
8.6.2. and Retail pharmacies. Market Forecast and Analysis
9. SMOKING CESSATION DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Smoking Cessation Drugs Market Overview
9.1.2 North America Smoking Cessation Drugs Market Forecasts and Analysis
9.1.3 North America Smoking Cessation Drugs Market Forecasts and Analysis - By Product
9.1.4 North America Smoking Cessation Drugs Market Forecasts and Analysis - By Distribution
9.1.5 North America Smoking Cessation Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Smoking Cessation Drugs Market
9.1.5.1.1 United States Smoking Cessation Drugs Market by Product
9.1.5.1.2 United States Smoking Cessation Drugs Market by Distribution
9.1.5.2 Canada Smoking Cessation Drugs Market
9.1.5.2.1 Canada Smoking Cessation Drugs Market by Product
9.1.5.2.2 Canada Smoking Cessation Drugs Market by Distribution
9.1.5.3 Mexico Smoking Cessation Drugs Market
9.1.5.3.1 Mexico Smoking Cessation Drugs Market by Product
9.1.5.3.2 Mexico Smoking Cessation Drugs Market by Distribution
9.2. EUROPE
9.2.1 Europe Smoking Cessation Drugs Market Overview
9.2.2 Europe Smoking Cessation Drugs Market Forecasts and Analysis
9.2.3 Europe Smoking Cessation Drugs Market Forecasts and Analysis - By Product
9.2.4 Europe Smoking Cessation Drugs Market Forecasts and Analysis - By Distribution
9.2.5 Europe Smoking Cessation Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Smoking Cessation Drugs Market
9.2.5.1.1 Germany Smoking Cessation Drugs Market by Product
9.2.5.1.2 Germany Smoking Cessation Drugs Market by Distribution
9.2.5.2 France Smoking Cessation Drugs Market
9.2.5.2.1 France Smoking Cessation Drugs Market by Product
9.2.5.2.2 France Smoking Cessation Drugs Market by Distribution
9.2.5.3 Italy Smoking Cessation Drugs Market
9.2.5.3.1 Italy Smoking Cessation Drugs Market by Product
9.2.5.3.2 Italy Smoking Cessation Drugs Market by Distribution
9.2.5.4 United Kingdom Smoking Cessation Drugs Market
9.2.5.4.1 United Kingdom Smoking Cessation Drugs Market by Product
9.2.5.4.2 United Kingdom Smoking Cessation Drugs Market by Distribution
9.2.5.5 Russia Smoking Cessation Drugs Market
9.2.5.5.1 Russia Smoking Cessation Drugs Market by Product
9.2.5.5.2 Russia Smoking Cessation Drugs Market by Distribution
9.2.5.6 Rest of Europe Smoking Cessation Drugs Market
9.2.5.6.1 Rest of Europe Smoking Cessation Drugs Market by Product
9.2.5.6.2 Rest of Europe Smoking Cessation Drugs Market by Distribution
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Smoking Cessation Drugs Market Overview
9.3.2 Asia-Pacific Smoking Cessation Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Smoking Cessation Drugs Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Smoking Cessation Drugs Market Forecasts and Analysis - By Distribution
9.3.5 Asia-Pacific Smoking Cessation Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Smoking Cessation Drugs Market
9.3.5.1.1 Australia Smoking Cessation Drugs Market by Product
9.3.5.1.2 Australia Smoking Cessation Drugs Market by Distribution
9.3.5.2 China Smoking Cessation Drugs Market
9.3.5.2.1 China Smoking Cessation Drugs Market by Product
9.3.5.2.2 China Smoking Cessation Drugs Market by Distribution
9.3.5.3 India Smoking Cessation Drugs Market
9.3.5.3.1 India Smoking Cessation Drugs Market by Product
9.3.5.3.2 India Smoking Cessation Drugs Market by Distribution
9.3.5.4 Japan Smoking Cessation Drugs Market
9.3.5.4.1 Japan Smoking Cessation Drugs Market by Product
9.3.5.4.2 Japan Smoking Cessation Drugs Market by Distribution
9.3.5.5 South Korea Smoking Cessation Drugs Market
9.3.5.5.1 South Korea Smoking Cessation Drugs Market by Product
9.3.5.5.2 South Korea Smoking Cessation Drugs Market by Distribution
9.3.5.6 Rest of Asia-Pacific Smoking Cessation Drugs Market
9.3.5.6.1 Rest of Asia-Pacific Smoking Cessation Drugs Market by Product
9.3.5.6.2 Rest of Asia-Pacific Smoking Cessation Drugs Market by Distribution
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Smoking Cessation Drugs Market Overview
9.4.2 Middle East and Africa Smoking Cessation Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Smoking Cessation Drugs Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Smoking Cessation Drugs Market Forecasts and Analysis - By Distribution
9.4.5 Middle East and Africa Smoking Cessation Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Smoking Cessation Drugs Market
9.4.5.1.1 South Africa Smoking Cessation Drugs Market by Product
9.4.5.1.2 South Africa Smoking Cessation Drugs Market by Distribution
9.4.5.2 Saudi Arabia Smoking Cessation Drugs Market
9.4.5.2.1 Saudi Arabia Smoking Cessation Drugs Market by Product
9.4.5.2.2 Saudi Arabia Smoking Cessation Drugs Market by Distribution
9.4.5.3 U.A.E Smoking Cessation Drugs Market
9.4.5.3.1 U.A.E Smoking Cessation Drugs Market by Product
9.4.5.3.2 U.A.E Smoking Cessation Drugs Market by Distribution
9.4.5.4 Rest of Middle East and Africa Smoking Cessation Drugs Market
9.4.5.4.1 Rest of Middle East and Africa Smoking Cessation Drugs Market by Product
9.4.5.4.2 Rest of Middle East and Africa Smoking Cessation Drugs Market by Distribution
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Smoking Cessation Drugs Market Overview
9.5.2 South and Central America Smoking Cessation Drugs Market Forecasts and Analysis
9.5.3 South and Central America Smoking Cessation Drugs Market Forecasts and Analysis - By Product
9.5.4 South and Central America Smoking Cessation Drugs Market Forecasts and Analysis - By Distribution
9.5.5 South and Central America Smoking Cessation Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Smoking Cessation Drugs Market
9.5.5.1.1 Brazil Smoking Cessation Drugs Market by Product
9.5.5.1.2 Brazil Smoking Cessation Drugs Market by Distribution
9.5.5.2 Argentina Smoking Cessation Drugs Market
9.5.5.2.1 Argentina Smoking Cessation Drugs Market by Product
9.5.5.2.2 Argentina Smoking Cessation Drugs Market by Distribution
9.5.5.3 Rest of South and Central America Smoking Cessation Drugs Market
9.5.5.3.1 Rest of South and Central America Smoking Cessation Drugs Market by Product
9.5.5.3.2 Rest of South and Central America Smoking Cessation Drugs Market by Distribution
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SMOKING CESSATION DRUGS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. SMOKING CESSATION DRUGS MARKET, KEY COMPANY PROFILES
12.1. BRITISH AMERICAN TOBACCO PLC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. DR.REDDY'S LABORATORIES
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. FOMTEM VENTURES
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GLAXOSMITHKLINE
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GSK
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. IMPERIAL TOBACCO
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JOHNSON AND JOHNSON
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. KIMREE TECHNOLOGY
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NICOTEK LLC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NJOY INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. British American Tobacco PLC
2. Dr. Reddy's Laboratories
3. Fontem Ventures
4. GlaxoSmithKline
5. GSK
6. Imperial Tobacco
7. Johnson & Johnson
8. Kimree Technology
9. Nicotek LLC
10. Njoy Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For